For decades, the standard advice was simple: get your first colonoscopy at fifty. That's what your doctor told you, that's what the guidelines said, and that's what most adults remembered. The number was so well-established it became a kind of folk wisdom — "fifty and finally a colonoscopy."
That number is wrong now. The current recommendation, adopted by the US Preventive Services Task Force in 2021 and now mirrored by most major guidelines including the American Cancer Society and increasingly Indian centres, is that average-risk adults should begin colorectal cancer screening at age 45, not 50.
The five-year shift is not bureaucratic. It is a response to one of the most quietly worrying epidemiologic trends in oncology: a steady, decade-over-decade rise in colorectal cancer among adults in their thirties and forties. The shift is meant to catch the first wave of those younger cancers before they become incurable.
The data behind the change
For the past twenty years, colorectal cancer incidence in adults over 65 has been declining — partly because of widespread screening (which finds and removes polyps before they become cancers), partly because of better treatment for established cancers. That's the success story.
Underneath that success, a different story has been unfolding. Colorectal cancer incidence in adults aged 25 to 49 has been rising at roughly two per cent per year — every year, for two decades. In some Indian metros (Mumbai, Delhi, Hyderabad), young-onset CRC is now among the fastest-growing cancers across all age groups. The classic patient — sixty-something, family history maybe, decades of asymptomatic polyp growth — is being joined by a newer pattern: a person in their late thirties or early forties presenting with rectal bleeding, change in bowel habits, or unexplained iron-deficiency anaemia. By the time they're worked up, the cancer is often locally advanced.
The reasons for this rise are still being debated. Diet shifts (more processed food, fewer high-fibre staples), microbiome changes, obesity, sedentary lifestyles, and possibly environmental exposures all contribute. The leading edge of research suggests early-life exposures — diet patterns established in childhood and adolescence — may matter more than late-life exposures. The full causal picture isn't yet settled. The screening implications, on the other hand, are.
What "screening at 45" actually means
For an average-risk adult — no first-degree relative with colorectal cancer, no personal history of inflammatory bowel disease, no known hereditary syndrome — the recommendation is simple: a baseline colonoscopy at age 45. If everything is normal, repeat every 10 years until age 75.
This is the gold-standard recommendation for one reason: colonoscopy doesn't just detect cancer; it prevents cancer. Most colorectal cancers grow over five to ten years from a small adenomatous polyp into invasive cancer. A colonoscopy doesn't just look — it removes any polyps it finds. Every polyp removed is a cancer that doesn't develop. That's a screening test that works as treatment.
When you should start earlier than 45
For people with elevated risk, the screening conversation begins earlier — sometimes much earlier:
- First-degree relative with colorectal cancer: start at age 40, or 10 years before your relative's age at diagnosis, whichever is earlier. So if your father was diagnosed at 47, start at 37.
- Two or more relatives, or any first-degree relative under 50: genetic counselling is the conversation. Family history matters more than most people realise.
- Inflammatory bowel disease (Crohn's, ulcerative colitis): screening typically begins 8-10 years after diagnosis with surveillance every 1-3 years.
- Lynch syndrome: colonoscopy every 1-2 years starting at age 20-25.
- Familial adenomatous polyposis: surveillance starts in the early teens.
- Personal history of adenomatous polyps: surveillance interval depends on the number, size, and histology of the polyps removed.
A colonoscopy doesn't just detect cancer. It prevents the cancer from happening in the first place.
What about FIT and stool DNA?
The fecal immunochemical test (FIT) is a non-invasive stool test that detects hidden blood. It's repeated annually, and a positive result triggers a colonoscopy. It's the most widely used population-screening test in many countries, and is reasonable for adults who can't or won't do a colonoscopy. The trade-off: FIT detects cancer earlier than no screening, but it doesn't prevent cancer because it doesn't remove pre-cancerous polyps. So a positive FIT often catches a cancer that's already invasive — at a curable stage, but not at the prevention stage.
Stool DNA tests (Cologuard in the US) combine a FIT with markers for cancer-associated DNA mutations. They're more sensitive than FIT alone but more expensive and not yet widely available in India. Repeat interval is every 3 years.
For high-risk patients, colonoscopy remains the standard. For average-risk adults who decline colonoscopy, annual FIT is a reasonable alternative — but it's a fall-back, not a substitute.
What to expect on the day
Colonoscopy is a 30-minute outpatient procedure done under sedation. The most onerous part is the bowel preparation the day before — drinking a litre of laxative solution and staying near a bathroom for several hours. The procedure itself is unremarkable for the patient. You arrive in the morning, change, are sedated, wake up an hour later, eat lunch, go home. Most people are back at work the next day.
Polyps found during the procedure are typically removed and sent for histological analysis. The results — number, size, type (tubular vs villous adenoma, serrated, hyperplastic), grade of dysplasia — determine your follow-up interval, which can range from a routine 10 years (clean exam) to 1 year (multiple high-risk adenomas). Your gastroenterologist will explain the result and the recommended interval.
If you're under 45 and have symptoms
The age-45 number is for asymptomatic screening. Symptoms — at any age — are a different conversation entirely. Persistent rectal bleeding, change in bowel habits lasting more than three weeks, unexplained iron-deficiency anaemia, persistent abdominal pain, or unexplained weight loss should prompt evaluation regardless of age. Most of these symptoms turn out to be benign (hemorrhoids, IBS, dietary issues), but the rate of "normal investigation" is what makes the rare malignancy stand out — and what makes the early diagnosis possible.
The biggest avoidable cause of late diagnosis in adults under 45 is the assumption that "I'm too young." The data on young-onset CRC has caught up with that assumption. The medical community is still catching up. As a patient, the practical implication is: if a symptom is persistent, get it evaluated. Don't wait until the screening age catches up to your concern.
The summary
For average-risk adults, schedule a baseline colonoscopy at 45. If you have a first-degree relative who had colorectal cancer, start earlier — by ten years before their diagnosis age. If you have symptoms at any age, get them evaluated. Repeat every ten years if the first one is clean. The procedure is brief, the bowel prep is the worst part, and the value — preventing a cancer rather than detecting one — is what makes this one of the highest-yield screening tools in medicine.